期刊
NANOMEDICINE
卷 16, 期 29, 页码 2633-2650出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2021-0255
关键词
cancer; immunometabolism; immunotherapy; iron oxide nanoparticles; metabolic reprogramming of tumor-associated macrophages
资金
- Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES]) [001]
Cancer immunotherapy focuses on activating the patient's immune system against cancer, while interest in metabolic reprogramming of tumor-associated macrophages has increased as a therapeutic strategy. Iron metabolism is a key in reprogramming macrophages to a tumor suppressor phenotype, with iron oxide nanoparticles emerging as a potential anti-tumor strategy.
Cancer immunotherapy is the most promising trend in oncology, focusing on helping or activating the patient's immune system to identify and fight against cancer. In the last decade, interest in metabolic reprogramming of tumor-associated macrophages from M2-like phenotype (promoting tumor progression) to M1-like phenotypes (suppressing tumor growth) as a therapeutic strategy against cancer has increased considerably. Iron metabolism has been standing out as a target for the reprogramming of tumor-associated macrophages to M1-like phenotype with therapeutic purposes against cancer. Due to the importance of the iron levels in macrophage polarization states, iron oxide nanoparticles can be used to change the activation state of tumor-associated macrophages for a tumor suppressor phenotype and as an anti-tumor strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据